{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:24:00Z","timestamp":1790234640184,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10067-019-04509-1","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T10:02:26Z","timestamp":1553508146000},"page":"1367-1373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients na\u00efve to anti-TNF therapy"],"prefix":"10.1007","volume":"38","author":[{"given":"Paola","family":"Reyes-Loyola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rodr\u00edguez-Henr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Ballinas-Verdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Amezcua-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneli","family":"Ju\u00e1rez-Vicu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valent\u00edn","family":"Jim\u00e9nez-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"M\u00e1rquez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"S\u00e1nchez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6258-5732","authenticated-orcid":false,"given":"Luis M.","family":"Amezcua-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"4509_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.imlet.2018.01.014","volume":"196","author":"F Babaie","year":"2018","unstructured":"Babaie F, Hasankhani M, Mohammadi H, Safarzadeh E, Rezaiemanesh A, Salimi R, Baradaran B, Babaloo Z (2018) The role of gut microbiota and IL-23\/IL-17 pathway in ankylosing spondylitis immunopathogenesis: new insights and updates. Immunol Lett 196:52\u201362","journal-title":"Immunol Lett"},{"key":"4509_CR2","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1002\/jcp.26500","volume":"233","author":"H Mohammadi","year":"2018","unstructured":"Mohammadi H, Hemmatzadeh M, Babaie F, Gowhari Shabgah A, Azizi G, Hosseini F, Majidi J, Baradaran B (2018) MicroRNA implications in the etiopathogenesis of ankylosing spondylitis. J Cell Physiol 233:5564\u20135573","journal-title":"J Cell Physiol"},{"key":"4509_CR3","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/fj.14-260323","volume":"29","author":"JL Marques-Rocha","year":"2015","unstructured":"Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Mart\u00ednez JA, Marti A (2015) Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J 29:3595\u20133611","journal-title":"FASEB J"},{"key":"4509_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cei.12089","volume":"173","author":"N-S Lai","year":"2013","unstructured":"Lai N-S, Yu H-C, Chen H-C, Yu CL, Huang HB, Lu MC (2013) Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol 173:47\u201357","journal-title":"Clin Exp Immunol"},{"key":"4509_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/14397595.2018.1453277","volume":"29","author":"W Yang","year":"2019","unstructured":"Yang W, Yan X, Xia Q, Tao Q, Gan X, Zhang Y, Chen Z, Kong W (2019) Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis. Mod Rheumatol 29:173\u2013180","journal-title":"Mod Rheumatol"},{"key":"4509_CR6","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s10067-015-3123-7","volume":"35","author":"MN Magrey","year":"2016","unstructured":"Magrey MN, Haqqi T, Haseeb A (2016) Identification of plasma microRNA expression profile in radiographic axial spondyloarthritis\u2014a pilot study. Clin Rheumatol 35:1323\u20131327","journal-title":"Clin Rheumatol"},{"key":"4509_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/BRS.0000000000001339","volume":"41","author":"B-P Qian","year":"2016","unstructured":"Qian B-P, Ji M-L, Qiu Y, Wang B, Yu Y, Shi W, Luo YF (2016) Identification of serum miR-146a and miR-155 as novel noninvasive complementary biomarkers for ankylosing spondylitis. Spine 41:735\u2013742","journal-title":"Spine"},{"key":"4509_CR8","doi-asserted-by":"publisher","first-page":"e0185323","DOI":"10.1371\/journal.pone.0185323","volume":"12","author":"K Prajzlerov\u00e1","year":"2017","unstructured":"Prajzlerov\u00e1 K, Grobeln\u00e1 K, Hu\u0161\u00e1kov\u00e1 M, Forejtov\u00e1 \u0160, J\u00fcngel A, Gay S, Vencovsk\u00fd J, Pavelka K, \u0160enolt L, Filkov\u00e1 M (2017) Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis. PLoS One 12:e0185323","journal-title":"PLoS One"},{"key":"4509_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/hmg\/ddy008","volume":"27","author":"C Perez-Sanchez","year":"2018","unstructured":"Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, Lopez-Pedrera C, Castro-Villegas MC, Abalos-Aguilera MC, Barbarroja N, Arias-de la Rosa I, Lopez-Montilla MD, Escudero-Contreras A, Lopez-Medina C, Collantes-Estevez E, Jimenez-Gomez Y (2018) Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients. Hum Mol Genet 27:875\u2013890","journal-title":"Hum Mol Genet"},{"key":"4509_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"4509_CR11","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, van den Bosch F, Listing J, Braun J, Landewe R, for the Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818","journal-title":"Ann Rheum Dis"},{"key":"4509_CR12","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"4509_CR13","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"4509_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.62.1.20","volume":"62","author":"LC Doward","year":"2003","unstructured":"Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, McKenna S, Tennant A, van der Heijde D, Chamberlain MA (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20\u201326","journal-title":"Ann Rheum Dis"},{"key":"4509_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1476-4598-12-92","volume":"12","author":"X Yan","year":"2013","unstructured":"Yan X, Liang H, Deng T, Zhu K, Zhang S, Wang N, Jiang X, Wang X, Liu R, Zen K, Zhang CY, Ba Y, Chen X (2013) The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells. Mol Cancer 12:92","journal-title":"Mol Cancer"},{"key":"4509_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbagrm.2017.02.010","volume":"1860","author":"X Jia","year":"2017","unstructured":"Jia X, Ouyang H, Abdalla BA, Xu H, Nie Q, Zhang X (2017) miR-16 controls myoblast proliferation and apoptosis through directly suppressing Bcl2 and FOXO1 activities. Biochimica Biophysica Acta Gene Regul Mech 1860:674\u2013684","journal-title":"Biochimica Biophysica Acta Gene Regul Mech"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04509-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:21:38Z","timestamp":1585009298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4509"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04509-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"24 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human studies were approved by the local ethics committee and were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}